𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mechanism of autoimmune hemolytic anemia in chronic lymphocytic leukemia

✍ Scribed by Zev M. Sthoeger; Dr. Dalia Sthoeger; Mordechai Shtalrid; Erica Sigler; David Geltner; Alain Berrebi


Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
538 KB
Volume
43
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Rituximab therapy for chronic lymphocyti
✍ Giovanni D'Arena; Luca Laurenti; Silvana Capalbo; Alfonso Maria D'Arco; Rosaria πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 94 KB πŸ‘ 2 views

Autoimmune hemolytic anemia (AIHA) is a well-known complication of chronic lymphocytic leukemia (CLL). In recent years the anti-CD20 monoclonal antibody rituximab has been used for the therapy of steroid-refractory AIHA and autoimmune thrombocytopenia, either idiopathic or in association with CLL. W